Announced
Completed
Financials
Sources
Tags
Acquisition
Private Equity
Friendly
Private
Completed
United States
verification panels
Single Bidder
Biotechnology
Majority
Domestic
Synopsis
GTCR-backed Cole-Parmer, a global manufacturer of proprietary products for fluidics, critical research and process equipment, completed the acquisition of ZeptoMetrix, a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases. Financial terms were not disclosed. "The addition of ZeptoMetrix is highly complementary to our existing product portfolio within the life sciences market. The acquisition underscores our dedication to serving our customers with unique, differentiated products that help accelerate their research & development programs and support their diagnostic workflows," Bernd Brust, Cole-Parmer Chief Executive Officer.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.